Exosomal vesicles derived from U937 cells and macrophages were lysed in RIPA lysis buffer. Antibodies against FAM53B (1:1000, A19236; Abclonal, Wuhan, China), GAPDH (1:2000, AC001; Abclonal) and Tubulin were used. Protein samples were adjusted to 0.375 mg/mL, 0.75 mg/mL, 1.5 mg/mL, 3 mg/mL, and Graphpad software (San Diego, CA, United States) was used to generate a standard protein curve. After washing, the membranes were incubated with peroxidase-labeled goat anti-rabbit secondary antibody (1:2000, AS014; Abclonal) at 37 °C for 1 h. The PKH67 Fluorescent Cell Linker Kit was used to identify and stain exosome suspensions. Diluent C (250 μL) was added to 50 μL of exosomes, followed by 1.5 µL diluent C (1.5 μL). The labeled and diluted exosomes were completely suspended with DMEM, and the exosomes were then added to the U937 cell (DAPI staining) culture supernatant with a pipette. After 24 h of culture, fixation, membrane rupture, and nucleation, laser scanning confocal fluorescence microscopy was used to observe whether U937 cells could take up macrophage-derived exosomes.
The gray value was detected by Image J software (version 1.8.0; National Institutes of Health, Bethesda, MA, United States), and the results were calculated by Graphpad Prism (version 9.0; GraphPad Software, San Diego, CA, United States).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.